Cross Country Healthcare, Inc. (CCRN) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals a mixed financial performance with some declines in specific areas, but overall positive developments such as strong cash position, strategic investments, and optimistic guidance for future growth. The Q&A section shows confidence in achieving ambitious revenue and margin targets, strategic focus on technology and acquisitions, and market stabilization. Although there are some declines in physician staffing and unclear responses regarding federal funding, the positive aspects outweigh the negatives, suggesting a likely positive stock price movement.
Key Financial Performance
Consolidated Revenue (Q4 2025) $237 million, down 5% sequentially and 24% year-over-year. The decline is attributed to the normalization of contingent utilization by clients across core Nurse and Allied businesses, particularly Travel, Nurse, and Allied.
Full Year Revenue (2025) $1.05 billion, down 22% year-over-year. The decline is due to prolonged normalization of contingent utilization by clients.
Gross Profit (Q4 2025) $48 million, representing a gross margin of 20.3%. Gross margin was down 10 basis points sequentially but up 30 basis points year-over-year. The fluctuation is due to mix shifts across the portfolio, partially offsetting margin pressure within travel.
Selling, General and Administrative Expense (Q4 2025) $51 million, up 9% sequentially and down 8% year-over-year. The increase sequentially includes nonrecurring severance costs related to the CEO change. Excluding these costs, SG&A would have been $43 million, representing a 19% year-over-year decline.
Adjusted EBITDA (Q4 2025) $4 million, representing 1.7% of revenue. The decline in margin is driven by revenue declines and bill pay spread compression, partially offset by cost savings.
Adjusted EBITDA (Full Year 2025) $27 million, representing 2.5% of revenue. The decline in margin is due to revenue declines and bill pay spread compression, partially offset by cost savings.
Nurse and Allied Revenue (Q4 2025) $194 million, down 4% sequentially and 24% year-over-year. The decline is driven by a reduction in travelers on assignment, while average bill rates remained stable.
Local and Per Diem Business Revenue (Q4 2025) $19 million, down 8% sequentially. The decline is attributed to seasonal factors, but the business operates with a gross margin close to the consolidated average.
Education Staffing Revenue (Q4 2025) $18 million, up 48% sequentially but down 7% year-over-year. The year-over-year decline is due to the in-sourcing of roles at larger clients.
Home-Based Staffing Revenue (Q4 2025) $34 million, up 34% year-over-year. Growth is attributed to the aging U.S. population and the cost-effectiveness of home-based care.
Physician Staffing Revenue (Q4 2025) $43 million, down 20% year-over-year and 12% sequentially. The decline is due to a reduction in billable days across top specialties, though revenue per day filled increased by 10% year-over-year.
Cash Position (End of Q4 2025) $109 million, with no outstanding debt. The company is well-positioned for strategic investments and share repurchases.
Cash Flow from Operations (Q4 2025) $18 million, contributing to $48 million for the full year. The cash flow includes merger-related costs and termination payments, which offset each other.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Intellify platform expansion: The company plans to expand its Intellify platform into home-based and education staffing markets in 2026, extending its reach into adjacent sectors.
Xperience platform: The Xperience mobile platform is actively used by healthcare professionals to discover opportunities and manage their careers digitally, enhancing engagement and retention.
Market share expansion: The company aims to expand its market share within large health systems and capture new clients across divisions.
New contracts: Successfully renewed, expanded, and won over $400 million in contract value, predominantly with MSP clients.
Operational efficiency: Investments in AI and ERP systems aim to improve speed to market, recruiter productivity, and back-office operations.
Cost management: Reduced U.S. headcount by 21% in 2025 and redeployed cost savings into revenue-producing roles like recruiters and sales professionals.
Strategic focus: The company is focusing on operational rigor, technology-powered workforce solutions, and disciplined capital allocation to drive long-term shareholder value.
Capital allocation: Plans to deploy capital for complementary acquisitions and share repurchases, supported by a strong balance sheet with over $100 million in cash.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Pending Merger Uncertainty: The pending merger introduced uncertainty for employees and customers, negatively impacting growth during 2025.
Tight Bill Pay Spread in Travel Staffing: The travel staffing business is experiencing tight bill pay spreads as competitors compete for market share, leading to margin pressure.
Decline in Revenue and Travelers on Assignment: Revenue for the Nurse and Allied segment, particularly in travel staffing, declined due to a reduction in travelers on assignment, impacting financial performance.
Margin Pressure in Travel Business: Continued margin pressure in the travel business is expected, with no immediate easing anticipated.
In-sourcing in Education Staffing: The Education Staffing business faced a decline due to the in-sourcing of roles at larger clients, impacting revenue.
Decline in Physician Staffing Revenue: The Physician Staffing segment experienced a decline in revenue due to reduced billable days in key specialties.
Headcount Reductions and Cost Management: Significant reductions in U.S. headcount and cost management efforts were necessary, reflecting operational challenges.
Impairment Charges and Tax Valuation Allowance: Noncash impairment charges and a valuation allowance on deferred tax assets were recorded, reflecting financial strain.
Competitive Pressures in Staffing Market: Competitors are aggressively competing for market share, creating challenges in maintaining and growing client relationships.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Growth: The company expects to return to revenue and earnings growth by the end of 2026, with a goal to exit 2026 with a revenue run rate north of $1 billion.
Adjusted EBITDA Margin: The company aims to achieve an adjusted EBITDA margin of 4% to 5% by the end of 2026, with a path to higher margins in 2027.
Market Trends: The healthcare staffing market, particularly travel staffing, is expected to stabilize and grow in 2026. Demand and bill rates are stabilizing, and clients are focusing on speed to fill rather than reducing contingent labor.
Technology Expansion: The company plans to expand its proprietary technology platform, Intellify, into home-based and education staffing markets in 2026. This is expected to enhance client value, improve efficiency, and create scalable recurring revenue streams.
Operational Efficiency: Investments in AI and ERP systems are expected to improve operational efficiency, speed to market, and recruiter productivity.
Revenue Producers: The company has added several dozen revenue producers, including recruiters, account managers, and sales professionals, to drive organic growth in 2026.
Capital Allocation: The company plans to deploy capital towards complementary acquisitions and share repurchases, supported by a strong balance sheet with over $100 million in cash.
Segment Performance: The home-based staffing business is expected to continue its strong growth trajectory, driven by an aging U.S. population. The education staffing business is anticipated to return to growth in 2026.
First Quarter 2026 Guidance: Revenue is projected to be between $235 million and $240 million, with an adjusted EBITDA margin of approximately 2%. The number of travelers on assignment is expected to rise by 2% compared to the fourth quarter of 2025.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Share Repurchase: In December, the company repurchased more than 800,000 shares of common stock, representing 2.5% of the shares outstanding, at an aggregate price of $6.8 million. Additionally, in the first quarter of 2026, the company continued share repurchases under its 10b5-1 trading plan, buying an additional 486,000 shares. The company anticipates making further share repurchases throughout the balance of the year, as it believes the stock does not reflect the underlying value of the business.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What is your confidence in achieving the goal of exiting 2026 with above $1 billion in revenue and 4%-5% EBITDA margins?
A:Kevin Clark expressed high confidence, citing a large sales pipeline, market-leading technology with Intellify, a strong balance sheet, and investments in revenue producers. William Burns added that margin improvement would come from operating leverage, offshoring work to India, and automation.
Q:What is your acquisition strategy going forward?
A:Kevin Clark stated they are focused on disciplined capital allocation, investing in technology platforms, and pursuing accretive tuck-in acquisitions in areas like home-based staffing and locums. They are also looking to consolidate where possible, leveraging their strong balance sheet.
Q:Can you provide more details about Intellify and its expansion into other markets?
A:Kevin Clark mentioned that Intellify is part of a whole house strategy to provide solutions across nursing, locums, and home-based staffing by 2026. The technology has been licensed to other companies and will be expanded across divisions later this year. Amiee Hawkins added that there is a healthy pipeline for these initiatives.
Q:How significant is the revenue from strike activity in the first quarter?
A:Kevin Clark and William Burns stated that revenue from strike activity is not material, amounting to single millions, and is not included in travel metrics.
Q:What is driving the sequential momentum going into Q2?
A:Kevin Clark and Marc Krug attributed the momentum to stabilization in orders, increased MSP orders, and investments in revenue producers. William Burns added that they have a clear view of Q2 performance due to 13-week assignments.
Q:Is the market turning or stabilizing, and how is the company performing?
A:Kevin Clark stated the market is stabilizing, with bill rates around $90-$95. The company is performing better than last year, leveraging technology and strategic decisions to grow above market averages.
Q:What are customers saying about changes to federal funding in healthcare?
A:Kevin Clark mentioned no unusual trends but noted a broader usage of contingent labor and an appetite for international nurse candidates.
Q:What is the outlook for sequential revenue progression in 2026?
A:William Burns expects sequential growth across all quarters, with year-over-year growth likely resuming in Q3 or Q4, driven by investments in various business lines.
Q:What impacted the locums business in Q4, and what is the outlook?
A:William Burns noted a broader pullback in larger specialties but expects sequential growth in Q2 as weekly production has already turned positive.
Q:How has the center of excellence in India progressed?
A:Kevin Clark stated the center has 700-800 employees handling various functions, including strategic sourcing, payroll, and IT. Amiee Hawkins added that automation efforts are yielding better results.
Q:What is the AI strategy across the enterprise?
A:Kevin Clark explained that AI is being infused across the enterprise, particularly in recruitment, credentialing, and delivery speed. The company aims to reduce costs and improve margins through AI-driven automation.
Q:What is the size and growth outlook for home-based staffing and education businesses?
A:William Burns stated home-based staffing is run-rating over $140 million annually with mid-single-digit sequential growth, while education is at $75 million annually and expected to resume growth this year.
Q:Do you have a pipeline for international staffing?
A:Kevin Clark stated they currently partner with others but see it as a potential area for future investment.
Q:Review of Unclear Management Responses
A:Management avoided directly addressing the impact of changes to federal funding in healthcare, providing only general observations about contingent labor and international nurse candidates.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI mean
AI speed
Becker article
CEO afternoon
CEO role
Chairman Chief
Chairman President
Chief Solutions
Co Founder
Country center
Country clinician
Country industry
Country rigor
Delivery Chief
ERP power
Founder Chairman
Healthcare merger
India pleasure
Intellify VMS
Intellify home
Intellify market
Officer Co
Officer belief
capital
care professional
focus
health care
health system
market share
objective
office
path
portfolio client
priority
producer
productivity
recruiter
strength
technology portfolio
workforce solution
CCRN Transcript
Cross Country Healthcare, Inc. (CCRN) Q4 2025 Earnings Call Transcript
Positive3-4
The earnings call reveals a mixed financial performance with some declines in specific areas, but overall positive developments such as strong cash position, strategic investments, and optimistic guidance for future growth. The Q&A section shows confidence in achieving ambitious revenue and margin targets, strategic focus on technology and acquisitions, and market stabilization. Although there are some declines in physician staffing and unclear responses regarding federal funding, the positive aspects outweigh the negatives, suggesting a likely positive stock price movement.
Cross Country Healthcare, Inc. (CCRN) Q3 2024 Earnings Call Transcript
Unknown11-7
The earnings call reveals several challenges: revenue and gross profit declines, competitive pressures, and margin compression. Despite share repurchases, the financial performance is weak with declining revenue and pressured margins. The Q&A highlights concerns about margin pressures and unclear future guidance, indicating potential uncertainties. The market strategy and financial health ratings are negatively impacted by these factors, leading to an overall negative sentiment.
Cross Country Healthcare, Inc. (CCRN) Q2 2024 Earnings Call Transcript
Unknown8-1
The earnings call presents a mixed picture: strong cash flow, share repurchases, and positive guidance on demand increase are offset by significant revenue decline, competitive pressures, and a substantial bad debt expense. The Q&A reveals optimism about demand but acknowledges competitive challenges and cost pressures. The neutral rating reflects these balanced positives and negatives, with no strong catalyst for significant stock price movement.
Cross Country Healthcare, Inc. (CCRN) Q1 2024 Earnings Call Transcript
Neutral5-2
CCRN Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
